Anti-PD1 (RetifanlimAb biosimilar) monoklonaal antilichaam
Gecertificeerd

Anti-PD1 (RetifanlimAb biosimilar) monoklonaal antilichaam

Catalog #: 12-9610-100
Maat: 100 µg

Kwaliteit

ISO Gecertificeerd

Levering

24-48 uur

Prijs -1%
Login voor prijs
BTW niet inbegrepen
Gratis verzending vanaf €100
Technische Documentatie

Technische Specificaties

Description

Retifanlimab (Zynyz), is an anti-cancer drug used for the treatment of Mercel cell Carcinoma. Retifanlimab is a Programmed death Receptor 1 (PD-1) blocking Monoclonal antobody. Retifanlimab blocks the interaction between PD-1 and its ligands PD-L1/2, and it acts as an immune checkpoint modulator.

Product Name Alternative

Zynyz

Host

• Humanized

Reactivity

Human

Target Antigen

PD-1

Applications

FACS

Components

Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution.

Storage Conditions

Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing) . Lyophilized antibodies are shipped at ambient temperature.

Applications Notes

FACS 1:100

Isotype

IgG4 (P108S)

Beschrijving

Retifanlimab (Zynyz), is an anti-cancer drug used for the treatment of Mercel cell Carcinoma. Retifanlimab is a Programmed death Receptor 1 (PD-1) blocking Mono

Specificaties

ProductnaamAnti-PD1 (RetifanlimAb biosimilar) monoklonaal antilichaam
Categorie
Beschikbare grootte100 µg
Catalogusnummer12-9610-100